Skip to main content
This page is marked noindex, nofollow and nosnippet: search engines are instructed not to index it, follow its links or reuse its content as a search-result excerpt. Citations and proposed references may contain errors or await review; this precaution limits reuse outside their evaluation context.

Citation test result: "McPartland, J. C., Bernier, R. A., & Jeste, S. S. (2021). Autism Biomarkers Consortium for Clinical Trials: Multisite studies of early deve…"

Read-only replay of the candidates recorded in the corpus, using the current calculation engine. No external search or new saved test was created.

Checked on · Calculation version 2026-11-17.10-j20

The bibliographic score measures concordance of the evaluated fields. It is not a probability of certainty or an assessment of the scientific quality of the study.

Share this result

This page is public for sharing but is marked noindex/nosnippet for search engines.

Submitted cited reference

Raw citation
McPartland, J. C., Bernier, R. A., & Jeste, S. S. (2021). Autism Biomarkers Consortium for Clinical Trials: Multisite studies of early development in ASD. Biological Psychiatry, 89(5), 411-420
Authors
McPartland, J.C.; Bernier, R.A.; Jeste, S.S.
Year
2021
Title
Autism Biomarkers Consortium for Clinical Trials: Multisite studies of early development in ASD
Journal
Biological Psychiatry
DOI
-
Volume / issue
89(5)
Pages
411-420

Best automated candidate

Low title correspondence: 50%
M1: Crossref, OpenAlex and PubMed Crossref Low title lexical similarity; no validated corresponding reference

Hamo, Ester; McPartland, James C.. (2022). Autism Biomarkers Consortium for Clinical Trials. Textbook of Autism Spectrum Disorders, Second Edition. doi:10.1176/appi.books.9781615379521.lg44

Divergent or partially matching elements: Authors, Title, Year, Journal. Year: 2021 cited; 2022 in the candidate record. Journal: Biological Psychiatry cited; Textbook of Autism Spectrum Disorders, Second Edition in the candidate record.

M1 is retained because its candidate score is higher than M2: 30/100 versus 25.2/100.

Candidate references (M1 and M2)

These are the candidates from each search channel before final metadata consolidation and validation.

Search channel Jaccard index Source Candidate reference
M1: Crossref, OpenAlex and PubMed 50.0% Crossref Hamo, Ester; McPartland, James C.. (2022). Autism Biomarkers Consortium for Clinical Trials. Textbook of Autism Spectrum Disorders, Second Edition. doi:10.1176/appi.books.9781615379521.lg44 https://doi.org/10.1176/appi.books.9781615379521.lg44

Low title correspondence: 50%

Divergent or partially matching elements: Authors, Title, Year, Journal. Year: 2021 cited; 2022 in the candidate record. Journal: Biological Psychiatry cited; Textbook of Autism Spectrum Disorders, Second Edition in the candidate record.

M2: Google Scholar via SerpApi 30.8% Google Scholar D Senturk; CA Sugar; SJ Webb. (2022). The autism biomarkers consortium for clinical trials: evaluation of a battery of candidate eye-tracking biomarkers for use in autism clinical trials. Molecular autism. doi:10.1186/s13229-021-00482-2 https://doi.org/10.1186/s13229-021-00482-2

Low title correspondence: 30.8%

Divergent or partially matching elements: Authors, Title, Year, Journal. Year: 2021 cited; 2022 in the candidate record. Journal: Biological Psychiatry cited; Molecular autism in the candidate record.

M1 is retained because its candidate score is higher than M2: 30/100 versus 25.2/100.

Bibliographic concordance score calculation

The score measures bibliographic concordance; it does not establish that a study exists or that its conclusions are valid.

Bibliographic concordance score : 30/100 · M1 · Title Jaccard : 50 %

Hamo, Ester; McPartland, James C.. (2022). Autism Biomarkers Consortium for Clinical Trials. Textbook of Autism Spectrum Disorders, Second Edition. doi:10.1176/appi.books.9781615379521.lg44

Low title correspondence: 50%

Divergent or partially matching elements: Authors, Title, Year, Journal. Year: 2021 cited; 2022 in the candidate record. Journal: Biological Psychiatry cited; Textbook of Autism Spectrum Disorders, Second Edition in the candidate record.

M1 is retained because its candidate score is higher than M2: 30/100 versus 25.2/100.

This score (30%) describes the concordance of available metadata for the automated candidate; it is not a validation status.

Evaluated fields: 4 out of 5.

Calculation details
Candidate comparison before metadata consolidation
Search channelCandidate score before consolidationTitle Jaccard
M130/10050.0 %
M225.2/10030.8 %
Authors
Cited
First author : McPartland, J.C.
Second author : Bernier, R.A.
Third author : Jeste, S.S.
Found
First author : Hamo, Ester
Second author : McPartland, James C.
Third author : Not provided
StatusScoreWeight
Non-concordant 0% 0.20
Title
Cited
Autism Biomarkers Consortium for Clinical Trials: Multisite studies of early development in ASD
Found
Autism Biomarkers Consortium for Clinical Trials
StatusScoreWeight
Non-concordant 50% 0.20
Year
Cited
2021
Found
2022
StatusScoreWeight
Partial 70% 0.20
Journal
Cited
Journal or publication source : Biological Psychiatry
Volume / issue : 89(5)
Found
Journal or publication source : Textbook of Autism Spectrum Disorders, Second Edition
Volume / issue : Not provided
StatusScoreWeight
Non-concordant 0% 0.20
DOI
Cited
Not provided
Found
10.1176/appi.books.9781615379521.lg44
StatusScoreWeight
Not present (absent) — -

(Authors 0.0x0.20 + Title 50.0x0.20 + Year 70.0x0.20 + Journal 0.0x0.20) / evaluated weight 0.80 (DOI absent: 0.20 removed) = 30.0

Engine version : 2026-11-17.10-j20

Learn more about the score calculation

Title Jaccard index: 50.0%

Shared significant words / union: 4 / 8.

Shared title tokens: biomarkers; clinical; consortium; trials

Missing title tokens: development; early; multisite; studies

Common words and autism-related domain terms are excluded. Singular/plural and behavior/behaviour variants are tolerated.

All candidate results

Autism Biomarkers Consortium for Clinical Trials

Selected by automated ranking Low title correspondence: 50% M1: Crossref, OpenAlex and PubMed Crossref Candidate score before consolidation (M1: Crossref, OpenAlex and PubMed) : 30.0%

Hamo, Ester; McPartland, James C.. (2022). Autism Biomarkers Consortium for Clinical Trials. Textbook of Autism Spectrum Disorders, Second Edition. doi:10.1176/appi.books.9781615379521.lg44

Divergent or partially matching elements: Authors, Title, Year, Journal. Year: 2021 cited; 2022 in the candidate record. Journal: Biological Psychiatry cited; Textbook of Autism Spectrum Disorders, Second Edition in the candidate record.

Authors
Cited
First author : McPartland, J.C.
Second author : Bernier, R.A.
Third author : Jeste, S.S.
Found
First author : Hamo, Ester
Second author : McPartland, James C.
Third author : Not provided
StatusScoreWeight
Non-concordant 0% 0.20
Title
Cited
Autism Biomarkers Consortium for Clinical Trials: Multisite studies of early development in ASD
Found
Autism Biomarkers Consortium for Clinical Trials
StatusScoreWeight
Non-concordant 50% 0.20
Year
Cited
2021
Found
2022
StatusScoreWeight
Partial 70% 0.20
Journal
Cited
Journal or publication source : Biological Psychiatry
Volume / issue : 89(5)
Found
Journal or publication source : Textbook of Autism Spectrum Disorders, Second Edition
Volume / issue : Not provided
StatusScoreWeight
Non-concordant 0% 0.20
DOI
Cited
Not provided
Found
10.1176/appi.books.9781615379521.lg44
StatusScoreWeight
Not present (absent) — -

(Authors 0.0x0.20 + Title 50.0x0.20 + Year 70.0x0.20 + Journal 0.0x0.20) / evaluated weight 0.80 (DOI absent: 0.20 removed) = 30.0

Title Jaccard index: 50.0%

Shared significant words / union: 4 / 8.

Shared title tokens: biomarkers; clinical; consortium; trials

Missing title tokens: development; early; multisite; studies

Common words and autism-related domain terms are excluded. Singular/plural and behavior/behaviour variants are tolerated.

The autism biomarkers consortium for clinical trials: evaluation of a battery of candidate eye-tracking biomarkers for use in autism clinical trials

Low title correspondence: 30.8% M2: Google Scholar via SerpApi Google Scholar Candidate score before consolidation (M2: Google Scholar via SerpApi) : 25.2%

D Senturk; CA Sugar; SJ Webb. (2022). The autism biomarkers consortium for clinical trials: evaluation of a battery of candidate eye-tracking biomarkers for use in autism clinical trials. Molecular autism. doi:10.1186/s13229-021-00482-2

Divergent or partially matching elements: Authors, Title, Year, Journal. Year: 2021 cited; 2022 in the candidate record. Journal: Biological Psychiatry cited; Molecular autism in the candidate record.

Authors
Cited
First author : McPartland, J.C.
Second author : Bernier, R.A.
Third author : Jeste, S.S.
Found
First author : D Senturk
Second author : CA Sugar
Third author : SJ Webb
StatusScoreWeight
Non-concordant 0% 0.20
Title
Cited
Autism Biomarkers Consortium for Clinical Trials: Multisite studies of early development in ASD
Found
The autism biomarkers consortium for clinical trials: evaluation of a battery of candidate eye-tracking biomarkers for use in autism clinical trials
StatusScoreWeight
Non-concordant 30.8% 0.20
Year
Cited
2021
Found
2022
StatusScoreWeight
Partial 70% 0.20
Journal
Cited
Journal or publication source : Biological Psychiatry
Volume / issue : 89(5)
Found
Journal or publication source : Molecular autism
Volume / issue : 13
StatusScoreWeight
Non-concordant
Cited volume/issue: 89(5); candidate: 13. These values differ.
0% 0.20
DOI
Cited
Not provided
Found
10.1186/s13229-021-00482-2
StatusScoreWeight
Not present (absent) — -

(Authors 0.0x0.20 + Title 30.8x0.20 + Year 70.0x0.20 + Journal 0.0x0.20) / evaluated weight 0.80 (DOI absent: 0.20 removed) = 25.2

Title Jaccard index: 30.8%

Shared significant words / union: 4 / 13.

Shared title tokens: biomarkers; clinical; consortium; trials

Missing title tokens: development; early; multisite; studies

Extra title tokens: battery; candidate; evaluation; eye-tracking; use

Common words and autism-related domain terms are excluded. Singular/plural and behavior/behaviour variants are tolerated.